Who founded Eugit Therapeutics?

Eugit Therapeutics was founded by Nizar Batada, Yoshi Fukazawa, George Church in 2022.

Who are Eugit Therapeutics's investors?

Eugit Therapeutics's investors include Y Combinator.

Where is Eugit Therapeutics headquartered?

Eugit Therapeutics is headquartered in San Francisco, US.

Eugit Therapeutics

YC S22

San Francisco, US · Founded 2022 · 2 employees · 1 known investors

Find your way into Eugit Therapeutics

1,585 people in our graph share verified history with the Eugit Therapeutics team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Nizar Batada · together at Stanford University (overlapped)

×4knows the team · via Broad Institute of MIT and Harvard

×2knows the team · via Harvard Medical School

knows the team · via Harvard University

×2knows the team · via Massachusetts Institute of Technology

knows the team · via Stanford University

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Also known as Eugit · Eugit Therapeutics Inc · EUGIT Tx

Biotech Healthtech Medical Devices Cell Therapy Synthetic Biology Therapeutics Oncology BiotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S22)

Eugit Therapeutics was founded in 2022 by Nizar Batada, Yoshi Fukazawa, and George Church.

Nizar Batada inCo-FounderHe previously worked as a scientist at 23andMe and held a tenure-track position at the University of Edinburgh, with a PhD in Biophysics from Stanford and research background in cancer genomics and bioinformatics.

Yoshi Fukazawa inVP of Research / Co-FounderYoshi Fukazawa is VP of Research and co-founder of Eugit Therapeutics, where he leads development of gamma delta T cell therapies. He brings extensive research background in immunology, virology, and cancer biology.

George Church inScientific Advisor / Co-FounderProfessor at Harvard and MIT with a PhD in molecular biology, Church developed foundational methods for direct genome sequencing and molecular multiplexing that contributed to next-generation sequencing technologies. He has founded multiple biotech companies spanning genomics, gene editing, and therapeutics, and directs PersonalGenomes.org, an open-access genomic data resource.

Investors · 1

Y CombinatorSan Francisco · $500K

In the news

Eugit Therapeutics - Arco Grantsarcogrants.com · Jan 2025

EUGIT Therapeutics – Next generation T cell based cancer immunotherapyycombinator.com · Jul 2022

Frequently asked questions

What does Eugit Therapeutics do?: Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.
Who founded Eugit Therapeutics?: Eugit Therapeutics was founded by Nizar Batada, Yoshi Fukazawa, George Church in 2022.
Who are Eugit Therapeutics's investors?: Eugit Therapeutics's investors include Y Combinator.
Where is Eugit Therapeutics headquartered?: Eugit Therapeutics is headquartered in San Francisco, US.